Home    Back

Rnl-vascostem®    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
47Buerger disease1

47. Buerger disease    [ 7 clinical trials,   9 drugs,   (DrugBank: 4 drugs),   4 drug target genes,   13 drug target pathways]
Searched query = "Buerger disease", "Thromboangiitis obliterans"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 7 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01302015
(ClinicalTrials.gov)		December 200717/2/2011Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's DiseaseSafety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's DiseaseBuerger's DiseaseBiological: RNL-Vascostem®R-BioNULLCompleted20 Years80 YearsAll15N/AKorea, Republic of